These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34748868)

  • 1. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms.
    Li X; Yu H; Gong Y; Wu P; Feng Q; Liu C
    J Ethnopharmacol; 2022 Feb; 284():114801. PubMed ID: 34748868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies.
    Liu C; Yu H; Li X; Gong Y; Wu P; Feng QS
    J Ethnopharmacol; 2022 Mar; 285():114913. PubMed ID: 34910953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks.
    Liu C; Huang R; Yu H; Gong Y; Wu P; Feng Q; Li X
    Phytomedicine; 2022 Aug; 103():154226. PubMed ID: 35689900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown and Overexpression Experiments to Investigate the Inhibitory Mechanism of Fuzheng Xiaozheng Prescription, an Effective Chinese Herbal Formula for the Clinical Treatment of Hepatocellular Carcinoma.
    Li X; Chen X; Yu H; Huang R; Wu P; Gong Y; Chen X; Liu C
    Pharmaceuticals (Basel); 2024 Aug; 17(9):. PubMed ID: 39338323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
    Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
    Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-glucaro-1,4-lactone improves Diethylnitrosamine induced hepatocellular carcinoma in rats via the uric acid-ROS pathway.
    Cai H; Zhang Y; Wang J; Deng Y; Liu J; Wu Z; Cao D; Song Z; Wang L; Xie B
    J Ethnopharmacol; 2024 Nov; 334():118569. PubMed ID: 38996947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
    Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
    J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
    Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
    J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mulberry fruit polysaccharides alleviate diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis in vivo: the roles of cell apoptosis and inflammation.
    Li S; Li Y; Sun H; Jiang Y; Pan K; Su Y; Bu N
    Bioengineered; 2021 Dec; 12(2):11599-11611. PubMed ID: 34866538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
    Chang W; He W; Li PP; Song SS; Yuan PF; Lu JT; Wei W
    Eur J Pharmacol; 2016 Aug; 784():173-80. PubMed ID: 27181068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A UPLC-QTOF/MS-based hepatic tissue metabolomics approach deciphers the mechanism of Huachansu tablets-based intervention against hepatocellular carcinoma.
    Chen C; Wu H; Fu X; Li R; Cheng H; Wang M; Zhou A; Zhang M; Li Q
    J Pharm Biomed Anal; 2024 Feb; 239():115875. PubMed ID: 38061172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
    Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
    Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
    Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
    J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary modulations of folic acid affect the development of diethylnitrosamine induced hepatocellular carcinoma in a rat model.
    Sharma R; Ali T; Negi I; Das A; Duseja A; Kaur J
    J Mol Histol; 2021 Apr; 52(2):335-350. PubMed ID: 33438102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS.
    Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X
    J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiota.
    Deng Z; Ouyang Z; Mei S; Zhang X; Li Q; Meng F; Hu Y; Dai X; Zhou S; Mao K; Huang C; Dai J; Yi C; Tan N; Feng T; Long H; Tian X
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116945. PubMed ID: 37490989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway.
    Tian X; Liu F; Wang Z; Zhang J; Liu Q; Zhang Y; Zhang D; Huang C; Zhao J; Jiang S
    J Ethnopharmacol; 2024 Mar; 322():117577. PubMed ID: 38104877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liuweiwuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signaling pathway.
    Chen Y; Song Z; Hou X; Liu J; Zheng C; Zhao X; Lv G; Li J; Xiu Y; Shi W; Zhao J; Yang H; Wang Y; Zhao J; Zhan X; Niu M; Zou W; Bai Z; Xiao X
    J Ethnopharmacol; 2024 Mar; 321():117406. PubMed ID: 37952733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice.
    Shi J; Zhu L; Tang BY; Yang WQ; Xi SY; Zhang CL; Li PF; Wang YJ; Guo KH; Huang JR; Huang CR; Yu ZX; Yu BK; Zhang CF; Zhang YM
    J Nat Med; 2024 Jun; 78(3):633-643. PubMed ID: 38704807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.
    Wang N; Feng Y; Tan HY; Cheung F; Hong M; Lao L; Nagamatsu T
    J Ethnopharmacol; 2015 Apr; 164():309-18. PubMed ID: 25700642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.